Literature DB >> 7674528

Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

C Brun-Buisson1, F Doyon, J Carlet, P Dellamonica, F Gouin, A Lepoutre, J C Mercier, G Offenstadt, B Régnier.   

Abstract

OBJECTIVE: To examine the incidence, risk factors, and outcome of severe sepsis in intensive care unit (ICU) patients. DESIGN AND
SETTING: Inception cohort study from a 2-month prospective survey of 11,828 consecutive admissions to 170 adult ICUs of public hospitals in France. PATIENTS: Patients meeting clinical criteria for severe sepsis were included and classified as having documented infection (ie, documented severe sepsis, n = 742), or a clinical diagnosis of infection without microbiological documentation (ie, culture-negative severe sepsis, n = 310). MAIN OUTCOME MEASURES: Hospital and 28-day mortality after severe sepsis.
RESULTS: Clinically suspected sepsis and confirmed severe sepsis occurred in 9.0 (95% confidence interval [CI], 8.5 to 9.5) and 6.3 (95% CI, 5.8 to 6.7) of 100 ICU admissions, respectively. The 28-day mortality was 56% (95% CI, 52% to 60%) in patients with severe sepsis, and 60% (95% CI, 55% to 66%) in those with culture-negative severe sepsis. Major determinants of both early (< 3 days) and secondary deaths in the whole cohort were the Simplified Acute Physiology Score (SAPS) II and the number of acute organ system failures. Other risk factors for early death included a low arterial blood pH (< 7.33) (P < .001) and shock (P = .03), whereas secondary deaths were associated with the admission category (P < .001), a rapidly or ultimately fatal underlying disease (P < .001), a preexisting liver (P = .01) or cardiovascular (P = .002) insufficiency, hypothermia (P = .02), thrombocytopenia (P = .01), and multiple sources of infection (P = .02). In patients with documented sepsis, bacteremia was associated with early mortality (P = .03).
CONCLUSIONS: Only three of four patients presenting with clinically suspected severe sepsis have documented infection. However, patients with clinically suspected sepsis but without microbiological documentation and patients with documented infection share common risk factors and are at similarly high risk of death. In addition to the severity of illness score, acute organ failures and the characteristics of underlying diseases should be accounted for in stratification of patients and outcome analyses.

Entities:  

Mesh:

Year:  1995        PMID: 7674528

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  226 in total

1.  Validity of earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for diagnosing catheter-related bacteremia in cancer patients.

Authors:  V B Malgrange; M C Escande; S Theobald
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  Treatment of sepsis with activated protein C.

Authors:  C J Hinds
Journal:  BMJ       Date:  2001-10-20

3.  O-antigen serotypes and type III secretory toxins in clinical isolates of Pseudomonas aeruginosa.

Authors:  Karine Faure; David Shimabukuro; Temitayo Ajayi; Leonard R Allmond; Teiji Sawa; Jeanine P Wiener-Kronish
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Looking at subgroups in an inhomogeneous population does not make these subgroups more homogeneous.

Authors:  Jean Carlet
Journal:  Intensive Care Med       Date:  2004-05-13       Impact factor: 17.440

5.  A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker.

Authors:  J Carlet
Journal:  Intensive Care Med       Date:  2004-04-09       Impact factor: 17.440

6.  A global perspective on the epidemiology of sepsis.

Authors:  Marc Moss; Gregory S Martin
Journal:  Intensive Care Med       Date:  2004-02-24       Impact factor: 17.440

7.  Counterpoint: should lactate clearance be substituted for central venous oxygen saturation as goals of early severe sepsis and septic shock therapy? No.

Authors:  Emanuel P Rivers; Ronald Elkin; Chad M Cannon
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

8.  Single-stranded DNA oligoaptamers: molecular recognition and LPS antagonism are length- and secondary structure-dependent.

Authors:  J L Ding; S T Gan; B Ho
Journal:  J Innate Immun       Date:  2008-07-12       Impact factor: 7.349

9.  The significance of non-sustained hypotension in emergency department patients with sepsis.

Authors:  Michael R Marchick; Jeffrey A Kline; Alan E Jones
Journal:  Intensive Care Med       Date:  2009-02-24       Impact factor: 17.440

10.  Early effects of catecholamine therapy on mucosal integrity, intestinal blood flow, and oxygen metabolism in porcine endotoxin shock.

Authors:  T Sautner; C Wessely; M Riegler; R Sedivy; P Götzinger; U Losert; E Roth; R Jakesz; R Függer
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.